Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis
Genetics
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis

27, Aug 2025

2
Ocrelizumab and the Role of NK Cells in Multiple Sclerosis
Genetics
Fewer Infusions, Same Protection? Rethinking Ocrelizumab Dosing in Multiple Sclerosis

25, Aug 2025

3
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis
Genetics
Ocrelizumab Rewrites the T-Cell Script in Early Multiple Sclerosis

25, Aug 2025

4
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis
Genetics
B Cells in the Spotlight: How Ocrelizumab Is Changing the Story of Multiple Sclerosis

23, Aug 2025

5
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response
Genetics
A Genetic Brake on Multiple Sclerosis: How SLC9A9 Shapes Treatment Response

22, Aug 2025

Categories:
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025

Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?
Genetics
Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?

12, Jun 2025